Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery

References

• Abdulrazik M, Tamilvanan S, Khoury K, Benita S. Ocular delivery of cyclosporin A II. Effect of submicron emulsion's surface charge on ocular distribution of topical cyclosporin A. STP Pharm Sci 2001; 11: 427–432
   Google Scholar
• Amini H, Ahmadiani A. Simple determination of cyclosporine in human whole blood by high-performance liquid chromatograpy. J Chromatogr B 2003; 795: 209–214
   PubMed Web of Science ®Google Scholar
• Attama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 2008; 355: 307–313
   PubMed Web of Science ®Google Scholar
• Bunjes H, Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, x-ray and neutron scattering. Adv Drug Deliv Rev 2007; 59: 379–402
   PubMed Web of Science ®Google Scholar
• CEDIA®. Cyclosporine PLUS Assay Specification Sheet. Microgenics Corporation, Fremont, VA 2006
   Google Scholar
• Cengiz E, Wissing SA, Müller RH, Yazan Y. Sunblocking efficiency of various TiO2-loaded solid lipid nanoparticle formulations. J Cosmet Sci 2006; 28: 371–378
   Google Scholar
• Choc G. Cyclosporine: Pharmacology. Cyclosporine. Clinical application in autoimmune diseases, DE Yocum. Harcourt Health Communications, Philadelphia, PA 2000; 15–29
   Google Scholar
• Demirel M, Yazan Y. Katı lipid nanopartiküller (SLN). FABAD 2000; 25: 167–179
   Google Scholar
• Fang J-Y, Fang C-L, Liu C-H, Su Y-H. Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur. Pharm Biopharm 2008; 70: 633–640
   PubMed Web of Science ®Google Scholar
• Gürsoy AZ. Oküler sistemler. Kontrollü Salım Sistemleri, AZ Gürsoy. Elma Bilgisayar Basım ve Ambalaj San.Tic.Ltd.şti, İstanbul 2002; 197–217
   Google Scholar
• Gokce EH, Sandri G, Bonferoni MC, Rossi S, Ferrari F, Güneri T, et al. Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm 2008; 364: 76–86
   PubMed Web of Science ®Google Scholar
• Hirunpanich V, Sugiyama E, Sato H. Ethyl docosahexaenoate decreased Neoral® absorption due to particle size enlargement. Int J Pharm 2008; 361: 251–252
   PubMedGoogle Scholar
• Jenning V, Mäder K, Gohla SH. Solid lipid nanoparticles (SLN™) based on binary mixtures of liquid and solid lipids: A 1H-NMR study. Int J Pharm 2000; 205: 15–21
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167–177
   PubMed Web of Science ®Google Scholar
• Kumar M, Singhal SK, Singh A. Development and validation of a stability indicating HPLC assay method for cyclosporine in cyclosporine oral solution USP. J Pharm Biomed Anal 2001; 25: 9–14
   PubMed Web of Science ®Google Scholar
• Lallemand F, Felt-Baeyens O, Besseghir K, Behar-Cohen F, Gurny R. Cyclosporine A delivery to the eye: A pharmaceutical challenge. Eur J Pharm Biopharm 2003; 56: 307–318
   PubMed Web of Science ®Google Scholar
• Lallemand F, Felt-Baeyens O, Rudaz S, Hamel AR, Hubler F, Wenger R, et al. Conversion of cyclosporine A prodrugs in human tears vs rabbits tears. Eur J Pharm Biopharm 2005a; 59: 51–56
   PubMed Web of Science ®Google Scholar
• Lallemand F, Furrer P, Felt-Baeyens O, Gex-Fabry M, Dumont JM, Besseghir K, et al. A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int J Pharm 2005b; 295: 7–14
   PubMed Web of Science ®Google Scholar
• Lee C-L, Jiang P-P, Sit W-H, Wan JM-F. Proteome of human T lymphocytes with treatment of cyclosporine and polysaccharopeptide: Analysis of significant proteins that manipulate T cells proliferation and immunosuppression. Int Immunopharm 2007; 7: 1311–1324
   PubMedGoogle Scholar
• Li Y, Wong HL, Shuhendler AJ, Rauth AM, Yu Wu X. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer–lipid hybrid nanoparticles. J Contr Rel 2008; 128: 60–70
   PubMed Web of Science ®Google Scholar
• Müller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–177
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge SA, Ravelli V. Thünemann AF, Mehnert W, Souto EB. 2008. Cyclosporine-loaded solid lipid nanoparticles (SLN®): Drug–lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 2008; 68: 535–544
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge SA, Ravelli V, Mehnert W, Thünemann AF, Souto EB. Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int J Pharm 2006; 317: 82–89
   PubMed Web of Science ®Google Scholar
• Manjunath K, Reddy JS, Venkateswarlu V. Solid lipid nanoparticles as drug delivery systems. Methods Find Exp Clin Pharmacol 2005; 27: 127–144
   PubMed Web of Science ®Google Scholar
• Olbrich C, Kayser O, Müller RH. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)—effect of surfactants, storage period and crystallinity. Int J Pharm 2002; 237: 119–128
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev 2007; 59: 411–418
   PubMed Web of Science ®Google Scholar
• Siekmann B, Westesen K. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles. Coll Surf B Bioint 1994; 3: 159–175
   Google Scholar
• Tamilvanan S, Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm 2004; 58: 357–368
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Khoury K, Gilhar D, Benita S. Ocular delivery of cyclosporin A I. design and characterization of cyclosporin A-loaded positively-charged submicron emulsion. STP Pharm Sci 2001; 11: 421–426
   Google Scholar